{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:10:22Z","timestamp":1791666622104,"version":"4.3.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Vulvodynia is a leading cause of dyspareunia in premenopausal women, causing considerable morbidity and sexual dysfunction. A multimodal approach is used to treat vulvodynia. Alongside psychosocial interventions and physiotherapy, pharmacological treatment such as oral gabapentin are used in the treatment of vulvodynia. Topical formulations of gabapentin have shown promise in animal models and case reports investigating its use in other pain conditions. The topical route also avoids the systemic complications of gabapentin such as somnolence, dizziness, and peripheral edema. This study aimed to perform a narrative synthesis of studies investigating the use of topical gabapentin in the treatment of vulvodynia. The primary outcome was a change in pain score following treatment with topical gabapentin. A broad literature search was performed, which identified four studies for inclusion. The included studies reported improved pain measures following treatment; however, conclusions cannot be made due to methodological heterogeneity and inherent limitations. These include lack of control arms, small sample sizes, lack of patient randomization, and use of combination treatments. Due to the paucity of evidence, this review supports the future implementation of double-blind randomized controlled trials to further investigate the efficacy of topical gabapentin in the treatment of vulvodynia.<\/jats:p>","DOI":"10.3389\/fpain.2023.1159268","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T05:54:50Z","timestamp":1688363690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of topical gabapentin in the treatment of vulvodynia: a narrative synthesis"],"prefix":"10.3389","volume":"4","author":[{"given":"Mehmet","family":"Ergisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tsatsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/J.JSXM.2016.02.167","article-title":"2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia","volume":"13","author":"Bornstein","year":"2016","journal-title":"J Sex Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/J.JSXM.2016.01.020","article-title":"Vulvodynia: assessment and treatment","volume":"13","author":"Goldstein","year":"2016","journal-title":"J Sex Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/AJP.0B013E31829EA118","article-title":"A comparison of demographic and psychosexual characteristics of women with primary versus secondary provoked vestibulodynia","volume":"30","author":"Brotto","year":"2014","journal-title":"Clin J Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41572-020-0164-2","article-title":"Vulvodynia","volume":"6","author":"Bergeron","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/J.DET.2010.07.002","article-title":"Vulvodynia: new concepts and review of the literature","volume":"28","author":"Groysman","year":"2010","journal-title":"Dermatol Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/J.JOGOH.2019.04.011","article-title":"Provoked vulvar vestibulodynia: epidemiology in Europe, physio-pathology, consensus for first-line treatment and evaluation of second-line treatments","volume":"48","author":"Bautrant","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40.e1","DOI":"10.1016\/J.AJOG.2013.09.033","article-title":"Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions","volume":"210","author":"Harlow","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/01.AOG.0000199951.26822.27","article-title":"Vulvodynia: characteristics and associations with comorbidities and quality of life","volume":"107","author":"Arnold","year":"2006","journal-title":"Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/00926230701866083","article-title":"Do psychosexual factors play a role in the etiology of provoked vestibulodynia? A critical review","volume":"34","author":"Desrochers","year":"2009"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01674820802604359","article-title":"Chronic stress in women with localised provoked vulvodynia","volume":"30","author":"Ehrstr\u00f6m","year":"2009","journal-title":"J Psychosom Obstet Gynecol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/IJERPH18126639","article-title":"Vulvodynia-it is time to accept a new understanding from a neurobiological perspective","volume":"18","author":"Torres-Cueco","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573397112666151231111104","article-title":"Neuroimaging of central sensitivity syndromes: key insights from the scientific literature","volume":"12","author":"Walitt","year":"2016","journal-title":"Curr Rheumatol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.PAIN.2005.05.025","article-title":"Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women","volume":"117","author":"Foster","year":"2005","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/JSM.12863","article-title":"Cognitive, psychophysical, and neural correlates of vulvar pain in primary and secondary provoked vestibulodynia: a pilot study","volume":"12","author":"Sutton","year":"2015","journal-title":"J Sex Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/S40265-019-01085-1","article-title":"Treatment of vulvodynia: pharmacological and non-pharmacological approaches","volume":"79","author":"Rosen","year":"2019","journal-title":"Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5114\/PM.2020.95337","article-title":"Aetiology, diagnosis, and clinical management of vulvodynia","volume":"19","author":"Vasileva","year":"2020","journal-title":"Prz Menopauzalny"},{"key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/OGX.0B013E3182277FB7","article-title":"Vulvodynia interventions\u2013systematic review and evidence grading","volume":"66","author":"Andrews","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.2147\/JPR.S126259","article-title":"Vulvodynia: a consideration of clinical and methodological research challenges and recommended solutions","volume":"10","author":"Corsini-Munt","year":"2017","journal-title":"J Pain Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/JDV.18102","article-title":"2021 European guideline for the management of vulval conditions","volume":"36","author":"van der Meijden","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B20","year":"2020","journal-title":"Neuropathic pain in adults: pharmacological management in non-specialist settings"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/14651858.CD007938.PUB4\/MEDIA\/CDSR\/CD007938\/IMAGE_N\/NCD007938-CMP-003-06.PNG","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"2017","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"89.e1","DOI":"10.1016\/J.AJOG.2018.10.021","article-title":"Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial","volume":"220","author":"Bachmann","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1213\/00000539-199912000-00026","article-title":"Gabapentin therapy for vulvodynia","volume":"89","author":"Ben-David","year":"1999","journal-title":"Anesth Analg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/AOG.0000000000002617","article-title":"Gabapentin for the treatment of vulvodynia: a randomized controlled trial","volume":"131","author":"Brown","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4111\/KJU.2013.54.1.48","article-title":"A retrospective study of the management of vulvodynia","volume":"54","author":"Jeon","year":"2013","journal-title":"Korean J Urol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/EJP.971","article-title":"Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model","volume":"21","author":"Shahid","year":"2017","journal-title":"Eur J Pain (London, England)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/AOG.0B013E3181827C77","article-title":"Topical gabapentin in the treatment of localized and generalized vulvodynia","volume":"112","author":"Boardman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/JDV.14096","article-title":"2016 European guideline for the management of vulval conditions","volume":"31","author":"van der Meijden","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/AJO.13292","article-title":"Topical treatment of vulvodynia, dyspareunia and pudendal neuralgia: a single clinic audit of amitriptyline and oestriol in organogel","volume":"61","author":"Ruoss","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/BMJ.B2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br Med J"},{"key":"B31","author":"Higgins","year":"2022"},{"key":"B32","year":""},{"key":"B33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/LGT.0000000000000318","article-title":"Vulvodynia-younger age and combined therapies associate with significant reduction in self-reported pain","volume":"21","author":"Aalto","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"B34","author":"Wells","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/BJD.13624","article-title":"Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin","volume":"173","author":"Hiom","year":"2015","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/2049463718762348","article-title":"Painful vulvodynia alleviated by topical gabapentin: a two-centre survey of treatment safety and efficacy","volume":"12","author":"Keevil","year":"2018","journal-title":"Br J Pain"},{"key":"B37","year":"2013"},{"key":"B38","year":""},{"key":"B39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/S00210-015-1145-Y","article-title":"A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin","volume":"388","author":"Ali","year":"2015","journal-title":"Naunyn-Schmiedeb Arch Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"671238","DOI":"10.3389\/fphar.2021.671238","article-title":"Effects of topical gabapentin on ocular pain and Tear Secretion","volume":"12","author":"Cammalleri","year":"2021","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40360-019-0329-3","article-title":"Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Shahid","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5489\/CUAJ.4976","article-title":"Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia","volume":"12","author":"Kim","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0029-7844(03)00368-5","article-title":"Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis","volume":"102","author":"Zolnoun","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1080\/00016340600883401","article-title":"EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis","volume":"85","author":"Danielsson","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B45","doi-asserted-by":"publisher","first-page":"189.e1","DOI":"10.1016\/J.AJOG.2020.08.038","article-title":"Multimodal physical therapy versus topical lidocaine for provoked vestibulodynia: a multicenter, randomized trial","volume":"224","author":"Morin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/AOG.0B013E3181E9E0AB","article-title":"Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial","volume":"116","author":"Foster","year":"2010","journal-title":"Obstet Gynecol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/LGT.0B013E3182449BD6","article-title":"Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia","volume":"16","author":"Pagano","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.36076\/ppj.2012\/15\/485","article-title":"Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort","volume":"15","author":"Poterucha","year":"2012","journal-title":"Pain Physician"},{"key":"B49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/LGT.0B013E31819663EE","article-title":"Topical amitriptyline-baclofen cream for the treatment of provoked vestibulodynia","volume":"13","author":"Nyirjesy","year":"2009","journal-title":"J Low Genit Tract Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/PM\/PNX013","article-title":"Topical gabapentin as add-on therapy for trigeminal neuralgia. A case report.","volume":"18","author":"Brid","year":"2017","journal-title":"Pain Medicine (Malden, Mass.)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/M18-2736","article-title":"Compounded topical pain creams to treat localized chronic pain: a randomized controlled trial.","volume":"170","author":"Brutcher","year":"2019","journal-title":"Ann Intern Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/IJD.14953","article-title":"A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus","volume":"59","author":"Aquino","year":"2020","journal-title":"Int J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e15767","DOI":"10.1111\/DTH.15767","article-title":"Topical gabapentin 10% in the treatment of epidermolysis Bullosa pruritus: a pilot, double-blind, split-site, randomized controlled trial","volume":"35","author":"Saki","year":"2022","journal-title":"Dermatol Ther"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2023.1159268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T05:54:53Z","timestamp":1688363693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2023.1159268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":53,"alternative-id":["10.3389\/fpain.2023.1159268"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2023.1159268","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"article-number":"1159268"}}